A common thread in some cancers is mutations in a developmental signaling pathway that ultimately affect the action of a single component.
No takes yet. Share an insight, caveat, or question.
Roel Nusse (2007) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: